Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants

Shuijing Wang; Yan Yu; Paul M. Ryan; Minyan Dang; Cain Clark; Vasileios Kontogiannis; Jamal Rahmani; Hamed Kord Varkaneh; Ammar Salehisahlabadi; Andrew S. Day; Yong Zhang

doi:10.1016/j.phrs.2019.104585

Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants

Shuijing Wang, Yan Yu, Paul M. Ryan, Minyan Dang, Cain Clark, Vasileios Kontogiannis, Jamal Rahmani, Hamed Kord Varkaneh, Ammar Salehisahlabadi, Andrew S. Day, Yong Zhang^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

43 Citations (SciVal)

Original language	English
Article number	104585
Journal	Pharmacological Research
Volume	151
DOIs	https://doi.org/10.1016/j.phrs.2019.104585
Publication status	Published (VoR) - Jan 2020

Keywords

Aspirin
Hepatocellular carcinoma
Liver cancer

Access to Document

10.1016/j.phrs.2019.104585

Cite this

Wang, S., Yu, Y., Ryan, P. M., Dang, M., Clark, C., Kontogiannis, V., Rahmani, J., Varkaneh, H. K., Salehisahlabadi, A., Day, A. S., & Zhang, Y. (2020). Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants. Pharmacological Research, 151, Article 104585. https://doi.org/10.1016/j.phrs.2019.104585

@article{780368d0fb3945fd9e2969e189456ffd,

title = "Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants",

keywords = "Aspirin, Hepatocellular carcinoma, Liver cancer",

author = "Shuijing Wang and Yan Yu and Ryan, \{Paul M.\} and Minyan Dang and Cain Clark and Vasileios Kontogiannis and Jamal Rahmani and Varkaneh, \{Hamed Kord\} and Ammar Salehisahlabadi and Day, \{Andrew S.\} and Yong Zhang",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2020",

month = jan,

doi = "10.1016/j.phrs.2019.104585",

language = "English",

volume = "151",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Elsevier",

}

Wang, S, Yu, Y, Ryan, PM, Dang, M, Clark, C, Kontogiannis, V, Rahmani, J, Varkaneh, HK, Salehisahlabadi, A, Day, AS & Zhang, Y 2020, 'Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants', Pharmacological Research, vol. 151, 104585. https://doi.org/10.1016/j.phrs.2019.104585

TY - JOUR

T1 - Association of aspirin therapy with risk of hepatocellular carcinoma

T2 - A systematic review and dose-response analysis of cohort studies with 2.5 million participants

AU - Wang, Shuijing

AU - Yu, Yan

AU - Ryan, Paul M.

AU - Dang, Minyan

AU - Clark, Cain

AU - Kontogiannis, Vasileios

AU - Rahmani, Jamal

AU - Varkaneh, Hamed Kord

AU - Salehisahlabadi, Ammar

AU - Day, Andrew S.

AU - Zhang, Yong

PY - 2020/1

Y1 - 2020/1

KW - Aspirin

KW - Hepatocellular carcinoma

KW - Liver cancer

UR - https://www.scopus.com/pages/publications/85076294424

UR - https://www.scopus.com/inward/citedby.url?scp=85076294424&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2019.104585

DO - 10.1016/j.phrs.2019.104585

M3 - Review article

C2 - 31816436

AN - SCOPUS:85076294424

SN - 1043-6618

VL - 151

JO - Pharmacological Research

JF - Pharmacological Research

M1 - 104585

ER -

Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants

Keywords

Access to Document

Other files and links

Fingerprint

Cite this